BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29177767)

  • 1. Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.
    Yu Q; Zhong C
    Neurosci Bull; 2018 Apr; 34(2):369-381. PubMed ID: 29177767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea-induced membrane fluidity decreasing as a characterization of neuronal membrane aging in Alzheimer's disease.
    Yu Q; Cheng X
    Aging (Albany NY); 2021 May; 13(9):12817-12832. PubMed ID: 33972461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K; Vink R; Martins R; Harvey A
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta.
    Salkovic-Petrisic M; Osmanovic J; Grünblatt E; Riederer P; Hoyer S
    J Alzheimers Dis; 2009; 18(4):729-50. PubMed ID: 19661616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
    Janota C; Lemere CA; Brito MA
    Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking brain imaging and genomics in the study of Alzheimer's disease and aging.
    Reiman EM
    Ann N Y Acad Sci; 2007 Feb; 1097():94-113. PubMed ID: 17413015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological significance of ganglioside clusters in Alzheimer's disease.
    Yanagisawa K
    J Neurochem; 2011 Mar; 116(5):806-12. PubMed ID: 21214549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arson. Tracking the culprit in Alzheimer's disease.
    Smith MA; Joseph JA; Perry G
    Ann N Y Acad Sci; 2000; 924():35-8. PubMed ID: 11193799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of gangliosides in Alzheimer's disease.
    Yanagisawa K
    Biochim Biophys Acta; 2007 Aug; 1768(8):1943-51. PubMed ID: 17321494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
    Duarte AI; Santos MS; Oliveira CR; Moreira PI
    Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific characterization and evaluation of the Alzheimer's disease genetic risk factor sorl1 in zebrafish during aging and in the adult brain following a 100 ppb embryonic lead exposure.
    Lee J; Peterson SM; Freeman JL
    J Appl Toxicol; 2017 Apr; 37(4):400-407. PubMed ID: 27535807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.